Live Breaking News & Updates on Taimei technology

Stay informed with the latest breaking news from Taimei technology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Taimei technology and stay connected to the pulse of your community

Dingdong Announces the Appointment of CFO and CHRO

Dingdong (Cayman) Limited fresh grocery e-commerce company announces appointment of CFO Mr. Song Wang and CHRO Ms. Hongli Gong.

Taimei , Anhui , China , Dingdong , Guangdong , Wellington , New-zealand-general- , New-zealand , Lianhua , Changlin-liang , Hongli-gong , Taimei-technology

Dingdong Announces the Appointment of CFO and CHRO

SHANGHAI, Dec. 26, 2023 /PRNewswire/ -- Dingdong Limited , a leading fresh grocery e-commerce company in China, today announced the appointment of Mr. Song Wang, currently the director and senior...

Dingdong , Guangdong , China , Yiguo , Yunnan , Taimei , Anhui , Tiangong , Sichuan , Weifang , Shandong , Shanghai

CRM Trial Connect 2023: Minister of Health Malaysia, Dr. Zaliha Mustafa visits Taimei Technology's booth

SHANGHAI, May 12, 2023 /PRNewswire/ --Taimei Technology, the digital platform for life science industry, attended CRM Trial Connect 2023 held at the InterContinental Kuala Lumpur from May 11 to May 12, 2023. During the event, Dr. Zaliha Mustafa, Minister of Health Malaysiavisited Taimei Technology's booth where she engaged in a discussion with the company's executives. Established by Malaysian Ministry of Health in 2012, Clinical Research Malaysia exists to advance global health solutions for a brighter, more hopeful future for the people by providing speedy and reliable end-to-end clinical research support for quality studies. CRM Trial Connect is now on its 2nd year, with more interesting program content developed for participating clinical research stakeholders! True to its form in being a one-stop event for multinational clinical trials in Malaysia, the program showcases Malaysia's capabilities, experiences and achievements in clinical research. As aleading digital platform for life science industry, Taimei Technology have conducted business in APAC, United States, Europe, Greater China and other countries/regions, providing pharmaceutical companies (sponsors)/CROs/sites with innovative digital solutions in the fields of clinical research, pharmacovigilance, and digital pharmaceutical marketing. Till now, Taimei Technologyis providing digital solutions to over 1,100 biopharmas and CROs, as well as to over 660 clinical trial organizations. In ASEAN, the company is building on its local presence by collaborating with Clinical Research Malaysia, CSI Medical Research and other leading organizations. About Taimei Technology Taimei Technology is a digital operation platform for the life science industry. We have conducted business in China, Asia Pacific, Europe, the United States and other countries/regions, providing pharmaceutical companies (sponsors)/CROs/sites with innovative technical solutions in the fields of clinical research, pharmacovigilance, and pharmaceutical marketing. Connect with us at: https://www.taimei.com/

China , Shanghai , United-states , Kuala-lumpur , Malaysia , Taimei , Anhui , Malaysian , Zaliha-mustafa , Taimei-technology , Health-malaysia , Clinical-research-malaysia

Taimei Technology opens Singapore office to support digital transformation of clinical research in APAC

SHANGHAI, Feb. 7, 2023 /PRNewswire/ --China-based Taimei Technology, a digital cooperationplatform for the life science industry, announced the opening of its new office in Singapore on February 1, 2023. The office, strategically located in one of the world's financial centres as well as one of APAC's economic and cultural centres, is expected to help accelerate the adoption of the company's innovative digital technologies for clinical research across the region and provide local customers with better services and experience with the support of local resources, while working with Taimei's partners to improve the application of digital technologies in regional clinical research and empower pharmaceutical innovations. Guests at the ribbon-cutting ceremony: Taimei Technology APAC BD head Sam Xu (first from left), National Healthcare Group (NHG) deputy CEO professor Benjamin Seet (second from left), Taimei Technology chairman and CEO Lu Zhao (middle), CSI Medical Research CEO Nelson Wong (second from right) and Taimei Technology vice president, general manager of clinical research business unit and APAC head Nate Zhang (first from right) Representatives from more than 20 organizations, including Integrated Health Information Systems (IHiS, an agency closely affiliated with Singapore's Ministry of Health (MOH)), National Healthcare Group (NHG), SingHealth, Singapore Clinical Research Institute (SCRI) and CSI Medical Research were invited to attend the opening ceremony for the new office. Taimei Technology chairman and CEO Lu Zhao said in his speech, "Taimei Technology has been committed to empowering innovative drugS' R&Dwith digital technologies since its inception. With our Drug R&D Digital Cooperation PlatformTrialOS, we have built a complete digital product system for clinical research and pharmacovigilance. Looking ahead, Taimei Technology plans to focus on its growth by increasing its investments in the APAC market through the new Singapore office, and facilitate the implementation of additional collaborative projects." Taimei Technology vice president, general manager of clinical research BU and APAC head Nate Zhang added, "Taimei Technology continues to implement its strategy of advancing platform-based clinical research by providing global customers with higher-quality services. With the TrialOS platform, we expect to further our collaboration withlocal customers and partners with the aim of accelerating the adoption of advanced digital technologies used in clinical research, improving the efficiency of clinical research operations, and speeding up the R&Dof new drugs to benefit more patients by providing them with easier access to effective and affordable drugs." Taimei Technology, a digital cooperation platform for the life science industry, and a market leader in the fields of digital clinical research, pharmacovigilance and pharmaceutical marketing, has become an important driver behind drug development breakthroughs in China. The company has established offices in the United States, Singapore, and the European Union, among other countries and regions, as it continues execute on its globalization roadmap in a move to support the development of new drugs worldwide through new digital technologies and practices for clinical research. Taimei Technology has developed partnerships with CSI Medical Research and IHiS.

China , United-states , Shanghai , Singapore , Taimei , Anhui , Sam-xu , Nelson-wong , Lu-zhao , Benjamin-seet , Nate-zhang , Singapore-clinical-research-institute

Worldwide Clinical Data Management System Industry to 2027 - Featuring BioClinica, Medidata and Oracle Among Others

/PRNewswire/ -- The "Clinical Data Management System Market, By Tools (Oracle Clinical, Clintrial, Macro, Rave and eClinicalSuite), Services (Case Report Form...

Germany , Japan , United-states , India , Taimei , Anhui , China , Canada , Dublin , Ireland , France , America

Worldwide Clinical Data Management System Industry to 2027 - Featuring BioClinica, Medidata and Oracle Among Others

/PRNewswire/ -- The "Clinical Data Management System Market, By Tools (Oracle Clinical, Clintrial, Macro, Rave and eClinicalSuite), Services (Case Report Form...

Germany , Japan , United-states , India , Taimei , Anhui , China , Canada , Dublin , Ireland , France , America

NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth

/PRNewswire/ -- NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $10+ million Series...

Xin-huang , Zhejiang , China , Shanghai , United-states , Taimei , Anhui , Pennsylvania , Tsingyuan , Hebei , State-college , Jonathan-sun

NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth – Business

NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth – Business
ipsnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ipsnews.net Daily Mail and Mail on Sunday newspapers.

Xin-huang , Zhejiang , China , Shanghai , United-states , Taimei , Anhui , Pennsylvania , Tsingyuan , Hebei , State-college , Jonathan-sun